APA (7th ed.) Citation

Y, R., & L, Q. (2026). Clinical response in advanced non-small cell lung cancer with high PD-L1 expression and MET exon 14 skipping mutation: A case analysis of overcoming immunotherapy resistance and literature review. Frontiers in oncology, 16, 1807242. https://doi.org/10.3389/fonc.2026.1807242

Chicago Style (17th ed.) Citation

Y, Ruan, and Qiu L. "Clinical Response in Advanced Non-small Cell Lung Cancer with High PD-L1 Expression and MET Exon 14 Skipping Mutation: A Case Analysis of Overcoming Immunotherapy Resistance and Literature Review." Frontiers in Oncology 16 (2026): 1807242. https://doi.org/10.3389/fonc.2026.1807242.

MLA (9th ed.) Citation

Y, Ruan, and Qiu L. "Clinical Response in Advanced Non-small Cell Lung Cancer with High PD-L1 Expression and MET Exon 14 Skipping Mutation: A Case Analysis of Overcoming Immunotherapy Resistance and Literature Review." Frontiers in Oncology, vol. 16, 2026, p. 1807242, https://doi.org/10.3389/fonc.2026.1807242.